Body Composition Analyzers Market to Register a Progressive CAGR Globally In Near Future
The proportion of water, protein, mineral, and fat, in the human body, aids in determining the health of an individual. To measure these, devices such as body composition analyzers are used in fitness centres and hospitals, for weight control. This equipment can be used in screening of certain diseases and conditions related to body weight and composition. Apart from this, it is also used in monitoring and prevention of conditions caused by excessive fat deposits such as diabetes, hyperlipidemia, cholelithiasis, and fatty liver. Furthermore, it aids in monitoring body composition changes in individuals, and to assess the effectiveness of nutrition and exercise programmers, both for health and physical fitness especially among obese population. According to World Health Organisation (WHO), 2017, the worldwide prevalence of obesity nearly tripled between 1975 and 2016. This increasing prevalence of obesity and increasing government initiatives to create awareness about obesity and its health issues related to obesity are factors expected to propel growth of the market.
To get holistic SAMPLE of the report, please click: https://www.coherentmarketinsights.com/insight/request-sample/1485
Body Composition Analyzers Market Dynamics
For example, InBody Co., Ltd. is one of the key players on the market that is engaged in manufacturing body composition analyzers. In October 2017, InBody Co., Ltd. launched band 2, which is fusion of body composition analyzers and fitness trackers. Integration of technologies such as Bluetooth wireless technology, BMI indicator, and past record tracker are expected to aid in increasing adoption of these devices. Furthermore, SELVAS Healthcare launched next generation body composition analyzer, ACCUNIQ BC380 with innovative software technologies and better product design, UI screens and result sheet in comparison to its old models. In addition to this, in 2015, this same company changed its name to Jawon Medical Co., Ltd. through a merger with HEAMS International, and launched two new products named X-SCAN PLUS 970, a body fat analyzer and COZY-930 Candy 5 HD II, a body composition and body water monitoring system.
According to WHO, 2016, 13% of the global population was overweight, which comprises 11% of men and 15% of women. Furthermore, according to OECD’s Obesity Update 2017 report, obesity rates of the U.S. was 38.2% and ranked the first, while Mexico ranked the second with 32.4%. Obese population is more prone to metabolic as well as weight related disorder such as osteoarthritis, heart diseases, diabetes, high blood pressure etc. Overweight and obesity as well as their related diseases are largely preventable. So awareness for weight related health issues and governmental initiatives for healthier life will aid in growth of body composition analyzer market. Increasing prevalence of obesity is one of the major factors fuelling growth of body composition analyzer market. However, high cost of the devices is expected to be a major factor hindering growth of body composition analyzers market.
To get detailed table of content (ToC), please click: https://www.coherentmarketinsights.com/ongoing-insight/toc/1485
Body Composition Analyzers Market – Regional Analysis
In terms of geography, the body composition analyzers market is segmented into North America, Europe, Asia Pacific, Middle East, Latin America, and Africa. U.S. is estimated to be dominant market in forecast period due to government initiatives to promote physical activity and advancement in technology. Asia Pacific is expected to be fastest growing body composition analyzer market due to increasing awareness about importance of weight management and fast development in healthcare sector.
Body Composition Analyzers Market – Competitors
Key players in the are Omron Corporation, Beurer GmbH, Tanita, InBody Co., Ltd, GE Healthcare, SECA, AccuFitness LLC, and Selvas Healthcare lnc. (Jawon medical Co. Ltd.).
You may be interested
Increasing funding in gene therapies is expected to fuel the growth of viral vectors and plasmid DNA manufacturing marketAlbert R - April 25, 2018
Gene therapy and genetically modified therapies are promising treatment option, which includes introduction of a normal or functional copy of a gene in the defective cell. Gene…
Increasing incidence of cancer is expected to fuel the growth of cancer metabolism based therapeutics marketAlbert R - April 25, 2018
According to the American Cancer Society (ACS), approximately 53,670 people are expected be diagnosed with pancreatic cancer and approximately 43,090 people are expected to die due to…
Innovation in technology to combat infectious diseases is expected to drive the future meningitis treatment marketAlbert R - April 25, 2018
Major driving factor for growth of the meningitis treatment market include the alliance of public and private sectors to increase availability of vaccine to the populace. For…